PHARMAP 2026 provides the platform for a key industry conversation: how leading pharmaceutical companies are further ...

GTC has been appointed by Barratt Redrow to deliver a fully integrated smart energy and utility infrastructure at Cosmeston ...

For now, H5N1 bird flu is not spreading efficiently from person to person. That is good news. But it is not a reason for ...

Outsourcing is no longer just about cost reduction. Pharma companies now seek strategic partnerships, agility and innovation, ...

Background: Although brain and heart conditions share overlapping risk factors and commonly co-occur, current cardiac and neurologic clinical guidelines are typically produced within specialty silos.

GSK’s planned investment of up to $800 million in its campus near Marietta got a $9 million boost from a state Redevelopment Capital Assistance Program grant earlier this year. The grant is part of ...

More than 20 years after gaining FDA approval for Flovent, GSK still controlled the market in the U.S. for the asthma inhaler through a partnership with an “authorized generic” dealer, a setup that ...

GSK struck a $950 million deal to buy Canada’s 35Pharma, a biopharmaceutical company developing cardiopulmonary treatments, as the U.K. drugmaker seeks to bolster its exposure to diseases linked to ...

GSK plc (NSE: GSK) on Wednesday agreed to acquire 35Pharma Inc. for $950 million. 35Pharma is a Canada-based, private, clinical-stage biopharmaceutical company specializing in the development of novel ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — Building up its base of medicines for lung diseases, GSK said ...

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Bora Pharmaceuticals Co., Ltd. (“Bora”; TWSE: 6472; OTCQX: BORAY), a global leader in pharmaceutical manufacturing, and GSK (LSE/NYSE: GSK) have signed a ...

The last time I wrote about GSK plc (GSK) for Seeking Alpha, it was late September, and I was covering the news that its CEO since 2017, Emma Walmsley, was stepping away from the role to be replaced ...